No photo of Olga Frankfurt

View Scopus Profile

Olga Frankfurt

  • 1380 Citations
19992023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Medical Oncology
Hematology

Training Experience

2002Residency, Rush University Medical Center
2005Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Chicago

… → 1999

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Transplants Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1999 2023

Prot #AML003: Phase III Multicenter Open-Label Randomized Trial to Evaluate Efficacy and Safety of CPI-613 in Combination With High Dose Cytarabine and Mitoxantrone (CHAM) Compared to High Dose Cytarabine and Mitoxantrone (HAM) in Older Patients (≥60 Year

Frankfurt, O.

Novella Clinical, LLC, Rafael Pharmaceuticals, Inc.

5/1/19 → 5/1/22

Project: Research project

Prot #APL2-302: A Phase III Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study to Evaluate the Efficacy and Safety of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Frankfurt, O.

Biorasi, LLC, Apellis Pharmaceuticals, Inc.

1/30/19 → 1/30/22

Project: Research project

Prot #GC P#05.01.020: A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, Umbilical Cord Blood-derived, Stem and Progenitor Cells, versus Unmanipulated Umbilical Cord Blood for Patients with Hematologic

Frankfurt, O.

Gamida Cell Ltd.

1/15/19 → 1/15/22

Project: Research project

Prot #INCB18424-MA-GD-301: An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

Frankfurt, O.

PAREXEL International Corporation, Incyte Corporation

11/28/18 → 11/28/21

Project: Research project

Prot #BST002: A Phase 2b, Open-Label, Single Arm, Multi-Center Study to Assess the Efficacy and Safety of BST-236 as a Single Agent in Adults with Newly-Diagnosed Acute Myeloid Leukemia, Not Eligible for Standard Induction Therapy

Frankfurt, O.

PRA Health Sciences, BioSight Ltd.

10/29/18 → 10/29/21

Project: Research project

Research Output 2004 2019

1 Citation (Scopus)

Identification and targeting of novel CDK9 complexes in acute myeloid leukemia

Beauchamp, E. M., Abedin, S. M., Radecki, S. G., Fischietti, M., Arslan, A. D., Blyth, G. T., Yang, A., Lantz, C., Nelson, A., Goo, Y. A., Akpan, I., Eklund, E. A., Frankfurt, O., Fish, E. N., Thomas, P. M., Altman, J. K. & Platanias, L. C., Mar 14 2019, In : Blood. 133, 11, p. 1171-1185 15 p.

Research output: Contribution to journal › Article

Cyclin-Dependent Kinase 9
Sirolimus
Acute Myeloid Leukemia
Cytoplasm
Chemical activation

Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin Lymphoma

Paudel, N., Schulze, D., Gentzler, R. D., Evens, A. M., Helenowski, I., Dillehay, G. L., Frankfurt, O., Mehta, J., Donnelly, E. D., Gordon, L. I., Winter, J. N. & Mittal, B. B., Jun 1 2019, In : International Journal of Radiation Oncology Biology Physics. 104, 2, p. 436-446 11 p.

Research output: Contribution to journal › Article

Lymphatic Irradiation
transplantation
stem cells
Stem Cell Transplantation
refractories

Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass

Bao, H., Gao, J., Chen, Y-H., Altman, J. K., Frankfurt, O., Wilson, A. L., Sukhanova, M., Chen, Q. C. & Lu, X., Mar 28 2019, In : Diagnostic pathology. 14, 1, 26.

Research output: Contribution to journal › Article

Open Access
Myeloid Sarcoma
Histiocytic Sarcoma
Uterine Hemorrhage
Neoplasms
Chromosomes, Human, Pair 18
42 Citations (Scopus)

Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia

DiNardo, C. D., Pratz, K., Pullarkat, V., Jonas, B. A., Arellano, M., Becker, P. S., Frankfurt, O., Konopleva, M., Wei, A. H., Kantarjian, H. M., Xu, T., Hong, W. J., Chyla, B., Potluri, J., Pollyea, D. A. & Letai, A., Jan 3 2019, In : Blood. 133, 1, p. 7-17 11 p.

Research output: Contribution to journal › Article

decitabine
Azacitidine
Acute Myeloid Leukemia
Cytogenetics
Therapeutics

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journal › Editorial

Pancreatitis
Population
blinatumomab